Browsing by Author Thomson, Damien

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2010Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized TrialBoland, Amy L.; Boyer, Michael; Gebski, Val; Grimison, Peter; Gurney, Howard; Simes, Robert John; Stockler, Martin; Craft, Paul; Harvey, V; Levi, John; Lewis, Craig; Olver, Ian N; Thomson, Damien; Toner, Guy C.; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial, Journal of the National Cancer Institute, vol.102, 16, 2010,pp 1253-1262
2016The effect of pulmonary function testing on bleomycin dosing in germ cell tumoursGrimison, Peter; Roncolato, Felicia; Stockler, Martin; Chatfield, Mark; Friedlander, Michael; Gurney, Howard; Houghton, Baerin B; Rosenthal, Mark; Thomson, Damien; Toner, Guy; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreThe effect of pulmonary function testing on bleomycin dosing in germ cell tumours, Internal Medicine Journal, vol.46, 8, 2016,pp 893-898
2005Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.Joshua, A; Kefford, Richard (Rick); Millward, Michael; Aamdal, Steinar; Hersey, Peter; Lynch, Kevin; Thomson, Damien; Toner, Guy C.; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; MedicineMulti-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma., Investigational New Drugs, vol.23,(3),2005,pp 253-256
2009O6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribKefford, Richard (Rick); Beith, Jane M.; Davis, I; Haydon, Andrew; Hersey, Peter; McArthur, Grant A.; McGown, G; Middleton, M. R.; Ranson, M; Thomson, Damien; Thorncraft, M; Watson, A. J.; Western Clinical School: Westmead Millennium InstituteO6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib, British Journal of Cancer, vol.100, 8,pp 1250-1256
2013Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyBoland, Amy; Chatfield, Mark; Gebski, Val; Grimison, Peter; McDonald, Angus; Olver, Ian Norman; Stockler, Martin; Davis, Ian; Harrup, Rosemary; Kichenadasse, G; Singhal, Nimit; Thomson, Damien; Toner, Guy; Underhill, Craig; Northern Clinical School: Medicine; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Ctr for Values Ethics & Law in Med; School of Public Health: NH&MRC Clinical Trials CentreResults of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy, Supportive Care in Cancer, vol.21, 6, 2013,pp 1561-1568